IC
ANIK icon

IEQ Capital’s Anika Therapeutics ANIK Stock Holding History

IEQ Capital’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Buy
33,466
+13,788
+70% +$204K ﹤0.01% 1413
2026
Q1 		$285K Buy
19,678
+9,609
+95% +$112K ﹤0.01% 1535
2025
Q4 		$96.8K Buy
+10,069
New +$96.4K ﹤0.01% 1764

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

IEQ Capital's ANIK Position: Q2 2026 in Review

IEQ Capital increased its Anika Therapeutics (ANIK) stake by 70% in Q2 2026, buying an estimated $204K and bringing the position to 33,466 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

IEQ Capital first reported a position in ANIK in Q4 2025 and has held it in 3 quarters since. 134 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • IEQ Capital held 33,466 shares of Anika Therapeutics worth $490K as of Q2 2026.
  • IEQ Capital bought 13,788 Anika Therapeutics shares in Q2 2026, an estimated $204K.
  • Anika Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1413 holding.
  • IEQ Capital first reported a position in Anika Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 134 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.